NCT02898194

Brief Summary

Background: Some people cannot make medical treatment decisions on their own. The people who make decisions on their behalf are called medical surrogates. Sometimes surrogates cannot predict which treatment course the person or their loved ones would have chosen. The surrogates often become distressed because of making these decisions. Researchers think a tool called a Patient Preference Predictor (PPP) may be able to make the process easier. The PPP would predict what treatment the person would want. This is based on treatment preferences of similar people in a similar circumstance. Researchers want to interview surrogates to explore their views on the PPP. Objective: To explore surrogates views on incorporating a PPP into shared medical decision-making. Eligibility: People 18 years or older who: Have acted as a surrogate medical decision-maker within the past 3 years. This includes decisions about treatment, medication, hospice care, hospital admission, or discharge. Are not pregnant Design: Participants will be screened by meeting with clinicians in person or by phone to discuss the study. Participants will take part in a focus group. This is a small group of people discussing their thoughts and opinions. This will last for about 2 hours. Participants will be served a light meal. Participants will provide information about themselves and their views. They will talk about their past experiences making medical decisions for someone. They will discuss how they felt about these decisions. The PPP will be explained to participants. They will give their views on it. The research team will audio record the focus group and take notes. Participants will fill out questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 13, 2016

Completed
2.3 years until next milestone

Study Start

First participant enrolled

December 31, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2020

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2020

Completed
Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

1.1 years

First QC Date

September 10, 2016

Last Update Submit

October 25, 2024

Conditions

Keywords

Surrogate Decision-makingHealth CareMedical DecisionsEnd of Life CareNatural History

Outcome Measures

Primary Outcomes (1)

  • Views of participants on PPP

    Level of acceptance regarding Patient Preference Predictor (PPP)

    Prior to, during, and immediately following the focus group session

Secondary Outcomes (1)

  • Views of Participants on PPP as patients

    Prior to, during, and immediately following the focus group

Study Arms (1)

1/Patient Surrogates

Any eligible participant who have acted as a surrogate medical decision-maker.

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any individual who acted as a surrogate decision maker for individuals undergoing any treatment.

You may qualify if:

  • years or older
  • Experience making at least one medical decision on behalf of an incompetent patient within the past 3 years. A medical decision for the purposes of this study is defined as making a decision in a context in which there was more than 1 feasible or reasonable option.
  • Ability to provide informed consent

You may not qualify if:

  • Inability to speak, understand, or read English
  • The patient on behalf of whom the individual acted as surrogate is deceased for less than two months.
  • In the view of the referring clinician, participation in the study is deemed excessively burdensome.
  • Candidate for study is pregnant
  • Court appointed surrogate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

St. Elizabeths Hospital

Washington D.C., District of Columbia, 20032, United States

Location

National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Shalowitz DI, Garrett-Mayer E, Wendler D. How should treatment decisions be made for incapacitated patients, and why? PLoS Med. 2007 Mar;4(3):e35. doi: 10.1371/journal.pmed.0040035. No abstract available.

    PMID: 17388655BACKGROUND
  • Rid A, Wendler D. Use of a patient preference predictor to help make medical decisions for incapacitated patients. J Med Philos. 2014 Apr;39(2):104-29. doi: 10.1093/jmp/jhu001. Epub 2014 Feb 13.

    PMID: 24526785BACKGROUND
  • Rid A, Wesley R, Pavlick M, Maynard S, Roth K, Wendler D. Patients' priorities for treatment decision making during periods of incapacity: quantitative survey. Palliat Support Care. 2015 Oct;13(5):1165-83. doi: 10.1017/S1478951514001096. Epub 2014 Oct 2.

    PMID: 25273677BACKGROUND

Related Links

Study Officials

  • David Wendler, Ph.D.

    National Institutes of Health Clinical Center (CC)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2016

First Posted

September 13, 2016

Study Start

December 31, 2018

Primary Completion

February 20, 2020

Study Completion

July 21, 2020

Last Updated

October 29, 2024

Record last verified: 2024-10

Locations